- Home
- MCBS vs ABSI Comparison
MCBS vs ABSI Comparison
Compare MCBS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | ABSI |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 997.8M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MCBS | ABSI |
|---|---|---|
| Price | $35.24 | $8.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $33.00 | $6.96 |
| AVG Volume (30 Days) | 59.0K | ★ 2.6M |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | 4.76 | ★ 10.64 |
| EPS | ★ 1.53 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $36.78 | $215.96 |
| Revenue Next Year | $2.44 | $319.10 |
| P/E Ratio | $22.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.53 | $2.24 |
| 52 Week High | $37.46 | $12.06 |
Technical Indicators
Market Signals| Indicator | MCBS | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 49.14 |
| Support Level | $35.06 | $8.55 |
| Resistance Level | $35.30 | $10.03 |
| Average True Range (ATR) | 0.66 | 0.61 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 35.12 | 24.32 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.